Social and Non-Profit
Jobs and Labor
Construction and Engineering
Oil and Gas
Fishing and Aquaculture
Metals and Mining
Pharmaceuticals and Biotechnology
Professional and Business Services
Forestry and Wood Industry
Books and Literature
Radio and Television
Home and Garden
Fashion and Luxury
Textile and Apparel
Travel and Hospitality
Boating and Yachting
Skiing and Winter Sports
The security settings of your browser are blocking the execution of scripts.
If you have changed your browser's security settings, you can click here.
American Beacon Funds
Annual Notice of Securities Sold (Form 24F-2NT)
Village of Oak Park, IL
Snowfall triggers parking restrictions
Cresco Labs Inc.
Cresco Labs Announces Launch of Khalifa Kush Products at Cookies[...]
Ikena Oncology Inc.
Management Change/Compensation - Form 8-K
Initial Statement of Beneficial Ownership (Form 3)
AVROBIO to Present at Cowen’s 2nd Annual Genetic Medicines Summit
07/02/2021 | Press release | Distributed by Public on 07/02/2021 11:29
May 12, 2021
Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al primo trimestre 2021, positiva pari a euro 104.668 migliaia, e prende atto dello stato di avanzamento dei trials principali Nidlegy™ e Fibromun in linea con le tempistiche previste (Price Sensitive)
Please select the service you want to use:
Please use the above public link if you want to share this noodl on another website.
| Philogen S.p.A.
| Company News
| Public Companies
| Biotechnology and Medical Research Companies
| Borsa Italiana
| Börse Frankfurt
| Börse Stuttgart
| SIGMA X MTF
View original format
Copyright ©2006-2022 Public Technologies Inc. |